What is nuchal translucency(NT)?
NT is an accredited screening process performed from 11 to 13+6 weeks of pregnancy. The fluid area behind the fetal neck is measured using ultrasound. The blood is measured for 2 naturally occurring hormones by the Fetal Medicine Centre’s laboratory. These blood results, combined with the ultrasound measurements determine the risk factor.
Nuchal translucency (NT) is the fluid that accumulates at the back of the neck of the developing fetus underlying the skin. The measurement of the nuchal translucency (NT) correlates with the risk for Down syndrome, fetal cardiac defects and other fetal defects. This measurement is obtained between 11 and 14 menstrual weeks.
